explore -WSS

explore

author：fashion 2025-09-29 01:37:13 - browse：69669

Two boxes of Ozempic stack on each other, while one lean on the stack tilted — health coverage from STAT — SEBASTIEN BOZON/AFP via Getty Images

Novo Nordisk’s Ozempic cut the risk of death in a trial of patients with type 2 diabetes and chronic kidney disease, suggesting it may offer some added benefits over other classes of drugs approved to treat this population.

Specifically, the diabetes drug cut the risk of cardiovascular-related deaths by 29% and all-cause deaths by 20%. Given the study parameters, this implies that over three years, 39 people would need to be treated to prevent one death from any cause, according to new results presented Friday at a meeting of the European Renal Association and published in the New England Journal of Medicine.

Ozempic also lowered the risk of major heart complications — including cardiovascular-related death, heart attack, or stroke — by 18%, driven primarily by the reduced rate of heart-linked death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Q&A: Jennifer Adair on making gene therapy available globally

WSS

John Green on his newest strategy for fighting tuberculosis

H5N1 bird flu virus started spreading in cows in Texas in December

Steward Health Care Massachusetts hospitals face fiscal disaster

FTC falls short on scrutinizing hospital mergers, study says

UnitedHealth financials solid despite Change Healthcare cyberattack

Melinda French Gates resigns from Gates Foundation

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

At least 13 dead in Texas as scorching temps continue

Boston's new lab space is opening empty

As demand for Covid shots wanes, Moderna seeks its next success

RaDonda Vaught links Vanderbilt hospital issues to patient death

Bright Health sells Medicare Advantage business to Molina

First U.S. drug developed to treat liver disease MASH is approved

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

H5N1 bird flu found in pasteurized milk: what we know

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why does health care cost so much? A reading guide

knowledge

H5N1 bird flu virus started spreading in cows in Texas in December

Exact Sciences stock tumbles despite strong cancer detection sales

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

WuXi out of biotech trade group, U.S. and China relations to blame

Change Healthcare outage fallout shows need for new oversight

Pushing for an NIH office for post

focus

hotspot

Wikipedia

focus